EP1041145A3 - Oligonucleotides labeled with stable isotopes and a method for detecting the same - Google Patents
Oligonucleotides labeled with stable isotopes and a method for detecting the same Download PDFInfo
- Publication number
- EP1041145A3 EP1041145A3 EP00106939A EP00106939A EP1041145A3 EP 1041145 A3 EP1041145 A3 EP 1041145A3 EP 00106939 A EP00106939 A EP 00106939A EP 00106939 A EP00106939 A EP 00106939A EP 1041145 A3 EP1041145 A3 EP 1041145A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- detecting
- same
- stable isotopes
- antisense
- oligonucleotides labeled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/312—Phosphonates
- C12N2310/3125—Methylphosphonates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/318—Chemical structure of the backbone where the PO2 is completely replaced, e.g. MMI or formacetal
- C12N2310/3181—Peptide nucleic acid, PNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3517—Marker; Tag
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11094323A JP2000290291A (en) | 1999-03-31 | 1999-03-31 | Stable isotope-labeled oligonucleotide and detection of oligonucleotide |
JP9432399 | 1999-03-31 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1041145A2 EP1041145A2 (en) | 2000-10-04 |
EP1041145A3 true EP1041145A3 (en) | 2003-12-17 |
EP1041145B1 EP1041145B1 (en) | 2006-10-18 |
Family
ID=14107087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00106939A Expired - Lifetime EP1041145B1 (en) | 1999-03-31 | 2000-03-31 | Oligonucleotides labeled with stable isotopes and a method for detecting the same |
Country Status (4)
Country | Link |
---|---|
US (3) | US20030073075A1 (en) |
EP (1) | EP1041145B1 (en) |
JP (1) | JP2000290291A (en) |
DE (1) | DE60031320T2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100626789B1 (en) * | 2002-04-12 | 2006-09-22 | 재단법인서울대학교산학협력재단 | A method for discriminating organic agricultural products from conventional agricultural products using the ratio of nitrogen isotope |
JPWO2006043521A1 (en) * | 2004-10-19 | 2008-05-22 | 日本新薬株式会社 | Optically active oligonucleic acid compound having phosphorothioate bond |
GB0604647D0 (en) * | 2006-03-08 | 2006-04-19 | Shchepinov Mikhail | Stabilized food supplements and their derivatives |
JP5448397B2 (en) | 2007-09-07 | 2014-03-19 | キヤノン株式会社 | Substrate probe, detection method of enzyme activity by multiple nuclear magnetic resonance method, and imaging method of enzyme activity |
WO2009046457A2 (en) * | 2007-10-05 | 2009-04-09 | Huntington Medical Research Institutes | Imaging of genetic material with magnetic resonance |
EP2276774B1 (en) | 2008-03-14 | 2016-08-17 | Retrotope, Inc. | Therapeutic substances that modulate genome methylation |
DK2493296T3 (en) | 2009-10-30 | 2019-04-15 | Retrotope Inc | REMOVAL OF OXIDATIVE STRESS STATES WITH PUFA DERIVATIVES |
AU2012249921B2 (en) | 2011-04-26 | 2017-06-08 | Biojiva Llc | Oxidative retinal diseases |
WO2012148926A2 (en) | 2011-04-26 | 2012-11-01 | Retrotope, Inc. | Neurodegenerative disorders and muscle diseases implicating pufas |
CA2834342C (en) | 2011-04-26 | 2021-08-31 | Retrotope, Inc. | Impaired energy processing disorders and mitochondrial deficiency |
JP6145087B2 (en) | 2011-04-26 | 2017-06-07 | レトロトップ、 インコーポレイテッドRetrotope, Inc. | Disorders involving PUFA oxidation |
CN102980937A (en) * | 2012-11-20 | 2013-03-20 | 中国食品发酵工业研究院 | Method for identifying organic coriander based on stable isotope ratio |
CN102967648A (en) * | 2012-11-20 | 2013-03-13 | 中国食品发酵工业研究院 | Method for identifying organic hot pepper based on stable isotope ratio |
EP3858843A1 (en) | 2015-11-23 | 2021-08-04 | Retrotope, Inc. | Site-specific isotopic labeling of 1, 4-diene systems |
WO2021168311A1 (en) | 2020-02-21 | 2021-08-26 | Retrotope, Inc. | Processes for isotopic modification of polyunsaturated fatty acids and derivatives thereof |
US12109194B2 (en) | 2021-02-05 | 2024-10-08 | Biojiva Llc | Synergistic combination therapy for treating ALS |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6153595A (en) * | 1990-08-16 | 2000-11-28 | Isis Pharmaceuticals Inc. | Composition and method for treatment of CMV infections |
US6020124A (en) * | 1992-04-27 | 2000-02-01 | Trustees Of Dartmouth College | Detection of soluble gene sequences in biological fluids |
JPH06319581A (en) * | 1993-03-15 | 1994-11-22 | Nippon Sanso Kk | Rna labeled with stabilized isotope and production of ribonucleotide |
JPH07115987A (en) * | 1993-10-21 | 1995-05-09 | Nippon Sanso Kk | Production of rna labeled with stable isotope |
JP3581877B2 (en) * | 1995-05-12 | 2004-10-27 | 独立行政法人産業技術総合研究所 | Functional molecular transporter |
-
1999
- 1999-03-31 JP JP11094323A patent/JP2000290291A/en active Pending
-
2000
- 2000-03-28 US US09/535,786 patent/US20030073075A1/en not_active Abandoned
- 2000-03-31 EP EP00106939A patent/EP1041145B1/en not_active Expired - Lifetime
- 2000-03-31 DE DE60031320T patent/DE60031320T2/en not_active Expired - Lifetime
-
2002
- 2002-08-07 US US10/214,503 patent/US7038036B2/en not_active Expired - Lifetime
-
2005
- 2005-10-11 US US11/248,852 patent/US20060051804A1/en not_active Abandoned
Non-Patent Citations (4)
Title |
---|
DELONG R K ET AL: "Comparative pharmacokinetics, tissue distribution, and tumor accumulation of phosphorothioate, phosphorodithioate, and methylphosphonate oligonucleotides in nude mice", ANTISENSE AND NUCLEIC ACID DRUG DEVELOPMENT, vol. 7, no. 2, 1997, pages 71 - 77, XP009019097, ISSN: 1087-2906 * |
DUNN B E ET AL: "Helicobacter pylori", CLINICAL MICROBIOLOGY REVIEWS 1997 UNITED STATES, vol. 10, no. 4, 1997, pages 720 - 741, XP002258427, ISSN: 0893-8512 * |
MACALLAN ET AL: "MEASUREMENT OF CELL PROLIFERATION BY LABELING OF DNA WITH STABLE ISOTOPE-LABELED GLUCOSE: STUDIES IN VITRO, IN ANIMALS, AND IN HUMANS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, no. 95, 1998, pages 708 - 713, XP002079486, ISSN: 0027-8424 * |
WEAVER L T: "Stable isotope breath tests.", NUTRITION (BURBANK, LOS ANGELES COUNTY, CALIF.) UNITED STATES OCT 1998, vol. 14, no. 10, October 1998 (1998-10-01), pages 826 - 829, XP002258370, ISSN: 0899-9007 * |
Also Published As
Publication number | Publication date |
---|---|
DE60031320T2 (en) | 2007-08-30 |
JP2000290291A (en) | 2000-10-17 |
EP1041145A2 (en) | 2000-10-04 |
US20030073075A1 (en) | 2003-04-17 |
DE60031320D1 (en) | 2006-11-30 |
US7038036B2 (en) | 2006-05-02 |
EP1041145B1 (en) | 2006-10-18 |
US20060051804A1 (en) | 2006-03-09 |
US20030104433A1 (en) | 2003-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1041145A3 (en) | Oligonucleotides labeled with stable isotopes and a method for detecting the same | |
EP2267138A3 (en) | Methods and means for obtaining modified phenotypes | |
Andrec et al. | Amide exchange rates in Escherichia coli acyl carrier protein: correlation with protein structure and dynamics | |
Shelke et al. | Site-directed nitroxide spin labeling of biopolymers | |
Summers et al. | Nuclear magnetic resonance and circular dichroism studies of a duplex-single-stranded hairpin loop equilibrium for the oligodeoxyribonucleotide sequence d (CGCGATTCGCG) | |
Werner et al. | NMR spectroscopic analysis of the DNA conformation induced by the human testis determining factor SRY | |
Heus et al. | Novel proton NMR assignment procedure for RNA duplexes | |
Scarfi et al. | Modified peptide nucleic acids are internalized in mouse macrophages RAW 264.7 and inhibit inducible nitric oxide synthase | |
RU2001124840A (en) | ANTITUMER ANTISEMIC SEQUENCES AIMED AT COMPONENTS R1 AND R2 OF RIB NUCLEOTID REDUCASE | |
GB2344823A (en) | Method for the preparation of a probe for nucleic acid hybridization | |
HK1044965A1 (en) | T cell receptor vbeta-beta-jbeta) sequence and methods for its detection | |
PL313445A1 (en) | Grb3-3 gene, variants thereof and their use | |
Chou et al. | On the relative ability of centromeric GNA triplets to form HairpinsversusSelf-paired duplexes | |
Wadkins et al. | The role of the loop in binding of an actinomycin D analog to hairpins formed by single-stranded DNA | |
AU7564491A (en) | New proteins, peptides and corresponding dna or rna sequences and probes useful for diagnosing tuberculosis | |
Mariappan et al. | Fragile X DNA triplet repeats,(GCC) n, form hairpins with single hydrogen-bonded cytosine· cytosine mispairs at the CpG sites: isotope-edited nuclear magnetic resonance spectroscopy on (GCC) n with selective 15N4-labeled cytosine bases | |
Brutscher et al. | Transverse relaxation optimized HCN experiment for nucleic acids: combining the advantages of TROSY and MQ spin evolution | |
EP0293079A3 (en) | Chlamydia vaccine | |
Delbarre et al. | Bisintercalation of ditercalinium into ad [CpGpCpG] 2 minihelix: Structure and dynamics aspects—a 400‐MHz 1H‐nmr study | |
Fazakerley et al. | NMR and CD studies on an oligonucleotide containing N 4-methylcytosine | |
Kintanar et al. | Effect of nucleoside modifications on the structure and thermal stability of Escherichia coli valinetRNA | |
Bendel et al. | Deuterium NMR in the solid-state and in solution of the molecular motion of the bases in poly (I) and poly (I)· poly (C) | |
Fazakerley et al. | [6] DNA mismatches and modified bases | |
WO2001092543A3 (en) | Improved methods of transfection | |
WO1999036517A3 (en) | Method for selecting ribozymes which are capable of covalently modifying the ribonucleic acids on 2'-oh-groups in trans |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
17P | Request for examination filed |
Effective date: 20040428 |
|
AKX | Designation fees paid |
Designated state(s): DE FR GB |
|
17Q | First examination report despatched |
Effective date: 20040909 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: TAIYO NIPPON SANSO CORPORATION |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): DE FR GB |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 60031320 Country of ref document: DE Date of ref document: 20061130 Kind code of ref document: P |
|
ET | Fr: translation filed | ||
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20070719 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20140328 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20140319 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20140319 Year of fee payment: 15 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 60031320 Country of ref document: DE |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20150331 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20151130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20151001 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150331 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150331 |